Aggressive lipid-lowering therapy and regression of coronary atheroma.

Suppr

超能文献

作者信息

Rajaram Kavitha

出版信息

JAMA. 2004 Jul 7;292(1):39; author reply 39-40. doi: 10.1001/jama.292.1.39-a.

DOI:10.1001/jama.292.1.39-a

PMID:15238582

Abstract

摘要

相似文献

Aggressive lipid-lowering therapy and regression of coronary atheroma.

JAMA. 2004 Jul 7;292(1):39; author reply 39-40. doi: 10.1001/jama.292.1.39-a.

Aggressive lipid-lowering therapy and regression of coronary atheroma.

JAMA. 2004 Jul 7;292(1):38-9; author reply 39-40. doi: 10.1001/jama.292.1.38-b.

Aggressive lipid-lowering therapy and regression of coronary atheroma.

JAMA. 2004 Jul 7;292(1):38; author reply 39-40. doi: 10.1001/jama.292.1.38-a.

Statins targeting inflammation by lowering low-density lipoprotein?

J Am Coll Cardiol. 2007 May 22;49(20):2010-2. doi: 10.1016/j.jacc.2007.03.011. Epub 2007 May 4.

Aggressive lipid-lowering therapy and regression of coronary atheroma.

JAMA. 2004 Jul 7;292(1):39; author reply 39-40. doi: 10.1001/jama.292.1.39-b.

[On the current debate on lowering LDL cholesterol with ezetimibe].

Dtsch Med Wochenschr. 2010 Nov;135(44):2201; author reply 2202. doi: 10.1055/s-0030-1267499. Epub 2010 Oct 26.

Optimal lipids, statins, and dementia.

J Am Coll Cardiol. 2005 Mar 15;45(6):963-4; author reply 964-5. doi: 10.1016/j.jacc.2004.12.019.

LDL-Cholesterol is the King.

Angiology. 2009 Jun-Jul;60(3):387-8. doi: 10.1177/0003319709334121. Epub 2009 Jun 3.

Lipid management with statins. The lower the better?

Z Kardiol. 2004 Jan;93(1):4-9. doi: 10.1007/s00392-004-1023-y.

Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment.

Lancet. 2003 Mar 1;361(9359):777-80. doi: 10.1016/s0140-6736(03)12663-3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Aggressive lipid-lowering therapy and regression of coronary atheroma.

JAMA. 2004 Jul 7;292(1):39; author reply 39-40. doi: 10.1001/jama.292.1.39-a.

Aggressive lipid-lowering therapy and regression of coronary atheroma.

JAMA. 2004 Jul 7;292(1):38-9; author reply 39-40. doi: 10.1001/jama.292.1.38-b.

Aggressive lipid-lowering therapy and regression of coronary atheroma.

JAMA. 2004 Jul 7;292(1):38; author reply 39-40. doi: 10.1001/jama.292.1.38-a.

Statins targeting inflammation by lowering low-density lipoprotein?

J Am Coll Cardiol. 2007 May 22;49(20):2010-2. doi: 10.1016/j.jacc.2007.03.011. Epub 2007 May 4.

Aggressive lipid-lowering therapy and regression of coronary atheroma.

JAMA. 2004 Jul 7;292(1):39; author reply 39-40. doi: 10.1001/jama.292.1.39-b.

[On the current debate on lowering LDL cholesterol with ezetimibe].

Dtsch Med Wochenschr. 2010 Nov;135(44):2201; author reply 2202. doi: 10.1055/s-0030-1267499. Epub 2010 Oct 26.

Optimal lipids, statins, and dementia.

J Am Coll Cardiol. 2005 Mar 15;45(6):963-4; author reply 964-5. doi: 10.1016/j.jacc.2004.12.019.

LDL-Cholesterol is the King.

Angiology. 2009 Jun-Jul;60(3):387-8. doi: 10.1177/0003319709334121. Epub 2009 Jun 3.

Lipid management with statins. The lower the better?

Z Kardiol. 2004 Jan;93(1):4-9. doi: 10.1007/s00392-004-1023-y.

Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment.

Lancet. 2003 Mar 1;361(9359):777-80. doi: 10.1016/s0140-6736(03)12663-3.